Swedencare (SECARE) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
23 Dec, 2025Executive summary
Q1 2025 delivered 7% revenue growth (5% organic), with operational EBITDA margin at 19.4% and strong cash flow, though EBITDA was down 10% year-over-year.
Major strategic moves included the acquisition of Summit Vet in the UK, Pack ApprovedĀ®, and early takeover of NaturVet's Amazon sales account, all expected to drive future growth and operational synergies.
Employee engagement improved, with eNPS rising from 41 to 44 and participation rate exceeding 80%.
Launched NaturVet's new brand design and expanded retail placements, including Walmart and PetSmart.
Tariffs and currency fluctuations had minimal impact due to local production and balanced exposure.
Financial highlights
Q1 revenue reached 641 million (7% growth, 5% organic, 2% currency), with operational gross margin stable at 58.1%.
EBITDA was 124.5 million, margin 19.4%, down from prior year.
Cash conversion improved to 78%, with operating cash flow at 96.7 million.
Net debt/EBITDA improved to 2.0, expected to rise to 2.5 post-Summit acquisition.
CAPEX remained below 2% of sales.
Outlook and guidance
Double-digit organic growth targeted for full year 2025, with margin improvements expected as extraordinary costs subside.
Summit Vet and NaturVet's Amazon account expected to boost revenue and profitability from Q2.
Focus on geographic expansion, operational efficiencies, and strengthening online/D2C sales.
Board proposes a dividend of 0.25 SEK per share for 2024.
Latest events from Swedencare
- Improved margins and strong sales drive a positive outlook as operational challenges ease.SECARE
Pre-close call20 Mar 2026 - Double-digit organic growth in Q4, but profitability declined due to one-off costs and disruptions.SECARE
Q4 202512 Feb 2026 - Q2 revenue up 10% with margin gains, strong European growth, and strategic acquisitions.SECARE
Q2 20243 Feb 2026 - Q3 saw 9% organic growth, higher margins, and strong European and dental segment gains.SECARE
Q3 202419 Jan 2026 - Q3 2025 saw record growth, robust margins, and new targets for global expansion and profitability.SECARE
SEB Nordic Seminar presentation16 Jan 2026 - Record sales and margins in 2024, with Europe and dental segments leading growth; NaturVet set for 2025 rebound.SECARE
Q4 202417 Dec 2025 - Record Q3 revenue and profitability, led by strong organic growth and U.S. retail expansion.SECARE
Q3 202514 Dec 2025 - Q2 2025 saw 3% sales growth and margin pressure, with double-digit growth expected in H2.SECARE
Q2 202516 Nov 2025